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Background & objectives: Awareness regarding obstructive sleep apnoea (OSA) among general
public as well as practicing physicians is low in India. The present study was undertaken to test
the utility of modified Berlin questionnaire for risk categorization of OSA in Indian setting.
Methods: The modified Berlin questionnaire was administered in 180 middle aged adults (of 320
screened), of whom, 104 underwent overnight polysomnograhy, in a cross-sectional study at a
tertiary care, referral center in north India. Questionnaire addressed the presence of frequency of
snoring, wake time sleepiness, fatigue, obesity and hypertension. Subjects with persistent and
frequent symptoms in any two of these three domains were considered in high risk category for
obstructive sleep apnoea. Overnight polysomnograhy was performed to measure apnoea and
hypopnoea index (AHI).
Results: Questions about the symptoms demonstrated internal consistency (Cronbach a correlations
0.92-0.96). Of the 180 respondents to the screening questions, 80 were in the high risk and the rest
were in low risk group. For 104 subjects who underwent polysomnograhy, risk grouping was useful
in prediction of AHI. High risk category predicted an AHI >5 with a sensitivity of 86 per cent,
specificity of 95 per cent, positive and negative predictive values of 96 and 82 per cent respectively.
These results were comparable to Berlin questionnaire study done in the western population for
validation.
Interpretation & conclusion: On the basis of the findings of present study it is concluded that
administration of modified Berlin questionnaire prior to a polysomnography study can identify
high risk subjects and can thus avoid unnecessary polysomnography studies especially in resource-
limited settings. To identify subjects at risk for OSA syndrome in general population, this
questionnaire can be applied. However, the findings of the present study need to be confirmed
further in a large number of subjects in a community-based setting.
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Obstructive sleep apnoea/hypopnoea syndrome
(OSAHS) and its manifestations have been known
for many centuries. It is a potentially disabling
condition characterized by excessive daytime
sleepiness, disruptive snoring, repeated episodes of
upper airway obstruction during sleep and nocturnal
hypoxemia. A population-based study1 of workers in
Wisconsin in 1993 found that 2 per cent of women
and 4 per cent of men had symptoms of daytime
sleepiness with OSA. Prevalence of OSA or OSAHS
from Wisconsin sleep cohort study done in USA and
studies from other countries was almost similar2-4. A
community-based study in middle-aged subjects from
New Delhi has reported prevalence of OSA and
OSAHS 13.7 and 3.6 per cent respectively5.
Recognition of OSA by the community physicians
all over the world is, however, low. In the Wisconsin
sleep cohort study community physicians diagnosed
only 7 per cent of women and 12 per cent of men
with moderate to severe illness to have OSA. Two
studies observed that specialist intervention with
diagnostic equipment6 or intensive physician
education on taking sleep history7 improved
recognition of OSA among primary care physicians.
However, both approaches required substantial
professional and technical resources.
Overnight polysomnography (PSG) is considered
to be the gold standard for diagnosis of OSA,
however, prohibitive cost of the test and long waiting
lists limit its widespread access. Although symptom
questionnaires have been developed to predict
presence of OSA, their overall reliability and utility
have not been established.
The Berlin questionnaire8 is an instrument
validated to use in the western population to
determine the occurrence of risk factors for OSAHS
namely snoring behaviour, wake-time sleepiness or
fatigue and the presence of obesity or hypertension.
The questions were selected from literature to elicit
factors or behaviours that, consistently predicted the
presence of sleep-disordered breathing9-14. The
questionnaire had symptoms about snoring, excessive
daytime sleepiness (EDS), obesity and hypertension.
Questions about these symptoms demonstrated
internal consistency (Cronbach a correlations15, 0.86
to 0.92). The Berlin questionnaire8 has been evaluated
in the population of Cleveland, Ohio with a
sensitivity of 86 per cent and specificity of 77 per
cent. No such study has been reported from India.
We used the set of screening questions (Annexure I)
and validation of the Berlin questionnaire8 with
certain modifications in Indian setting and named it
modified Berlin questionnaire (Annexure II) for risk
categorization of OSA.
Material & Methods
Patient selection: The study was conducted at the
All India Institute of Medical Sciences (AIIMS)
hospital, a tertiary level referral center at New Delhi,
India. The study protocol was reviewed and cleared
by the departmental research committee and
institutional review board of the All India Institute
of Medical Sciences. Informed written consent was
obtained from all patients. Subjects for the study
selected from the patients attending medical
outpatient department of AIIMS from April 2000 to
April 2002. Subjects of either gender in the age group
of 18-60 yr, qualifying the set of screening questions
(Annexure I), and residents of New Delhi and nearby
areas were considered eligible. Patients with history
of alcoholism, chronic anxiolyatic/sedative drug use,
associated respiratory, renal, hepatic or
cardiovascular disease or upper respiratory tract
infection within the past one week as well as those
who were pregnant or critically ill were excluded.
Subjects who expressed their intention to
participate and satisfied above criteria were
administered screening questionnaire (Annexure I).
Modification in the Berlin questionnaire (Annexure
II) included changes in the questions in category 2.
As driving is not common in India, we included
questions more on wake-time sleepiness such as
history of sleepiness while waiting for an
appointment with the doctor, while watching
television at home, or while waiting in the queue
to make payment of telephone or electricity bill.
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All subjects were explained about details of the study.
A total of 320 consecutive subjects were administered
screening questionnaire. Of these, 180 subjects gave
at least one positive response to the four screening
questions of the questionnaire (Annexure I). All the
180 subjects were requested to fill in the proforma
and the modified Berlin questionnaire (Annexure II)
themselves, preferably in the presence of subjects’
bed partners. Subjects who could not read and write
were administered the questionnaire by the first
author (SKS) with the help of their bed partners.
Locally translated version (Hindi) of questionnaire
was used for subjects who could not read and write
English. The Hindi questionnaire was back translated
into English with no difference in the meaning
conveyed.
Risk categorization: Subjects were divided into high
risk and low risk categories on the basis of modified
Berlin questionnaire and risk categorization as
described under Berlin study results8. A 4-point
frequency scale [0- never, 1- rarely (1-2/month), 2-
sometimes (1-2/wk), 3-frequently (3-4/wk), 4-always
(>4/wk)] was used for defining various indices like
snoring, choking, caffeine and alcohol index.
Subjects smoking was given score according to the
following criteria: 0- never, 1- (1-2 cigarettes or
beedies/day), 2- (3-5 cigarettes or beedies/day), 3-
(5-10 cigarettes or beedies/day), 4- (> 10 cigarettes
or beedies/day). Pre-determination of high risk and
lower risk for sleep apnoea or syndrome was based
on responses in three symptom categories. In category
1, high risk was defined as persistent symptoms (>3
to 4 times/wk) in two or more questions about their
snoring. In category 2, high risk was defined as
persistent symptoms (>3 to 4 times/wk) in two or
more questions about their wake time sleepiness. In
category 3, high risk was defined as a history of high
blood pressure as per the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment
of High Blood Pressure (JNC VI)16 or a body mass
index (BMI)17 >25 kg/m2. To be considered high risk
for obstructive sleep apnoea syndrome, patients had
to qualify as high risk for at least two symptom
categories. Those who denied having persistent
symptoms or who qualified for only one symptom
category were placed in the low risk group. Eighty
subjects were in high risk and 100 were in low risk
category.
A detailed physical examination was done in all
subjects. Blood pressure was measured with a
mercury sphygmomanometer to the nearest 2 mmHg
in recumbent position after at least five minutes of
rest. Subjects were advised to refrain from smoking
or ingesting caffeine for 30 min prior to blood
pressure measurement. A variety of large cuff sizes
was used wherever necessary to ensure that bladder
length was at least 80 per cent of the arm
circumference. In case of an abnormal blood pressure
recording, another reading was obtained after 5 min
of rest. An average of six readings of systolic and
diastolic pressure on two occasions was taken for
analysis. The mercury sphygmomanometer was
periodically validated against a Hawksley Random
Zero Sphygmomanometer (Hawksley, Lancing,
Sussex, UK). A history of antihypertensive
medication intake was also recorded in subjects with
hypertension.
Hypertension was classified as per the JNC VI16:
the optimal BP (systolic pressure of <120 mm Hg
and diastolic pressure of <80 mm Hg), normal
(systolic pressure of 120 to 129 mm Hg or diastolic
pressure of 80 to 84 mm Hg), or high normal (systolic
pressure of 130 to 139 mm Hg or diastolic pressure
of 85 to 89 mm Hg). If the systolic and diastolic blood
pressure readings belonged to different categories,
then higher of the two readings was used to assign
the blood-pressure category.
A specialist otorhinolaryngologist, blinded to PSG
findings, carried out examination of upper airway in
all subjects included in the study. A specific note of
the following abnormalities was made: macroglossia,
pharyngeal crowding, bulky uvula, retrognathia,
tonsillar enlargement and deviated nasal septum.
All subjects underwent complete blood count
(CBC), liver and renal function tests, lipid profile,
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chest radiograph, 12-electrocardiogram and lung
function testing. The following spirometry variables
were also analyzed; Forced vital capacity (FVC),
forced expired volume in one second (FEV1), peak
expiratory flow rate (PEFR) and ratio of forced
expired volume in one second and forced vital
capacity (FEV1/FVC). Lung volumes and their
subdivisions were measured by using a constant
volume variable pressure body plethysmograph (P.K.
Morgan Chatham, Kent, UK).
Anthropometric profile: Body weight was recorded (to
nearest 0.5 kg) in all patients, in erect position without
shoes and wearing only light indoor clothes, with an
electronic scale (Tanita body composition analyzer-TBF
300 G.S., Japan). Height was measured to the nearest
1 cm and body mass index (BMI) was calculated as
body weight/height2 (kg/m2). Neck circumference (NC)
was measured at the level of cricothyroid membrane
using a non-elastic measuring tape. Neck length (NL)
was measured from occipital tubercle to the vertebra
prominens. A height-corrected measure for NC,
percentage predicted neck circumference (PPNC) was
computed using the formula, PPNC = (1000 x NC)/
(0.55 H+310). Waist circumference was measured
midway between the lower rib cage margin and the
anterior superior iliac spine. Hip circumference was
measured at the maximum circumference of the
buttocks, the subject standing with feet placed together
and waist-hip ratio (W-HR) was calculated.
Skinfold thickness was measured using Lange
skinfold calipers (Beta Technology Inc., Santa Cruz,
CA, USA) to the nearest 1 mm. Mid arm
circumference (cm) was measured at the level of mid
arm taking acromion process and olecranon as
reference points. Triceps and biceps skinfold
thicknesses were measured midway between the
acromion process of scapula and the olecranon
process. Subscapular skinfold thickness (SSFT) was
measured at the inferior angle of scapula in mid-
axillary line and suprailiac skinfold thickness
measured just above the highest point of iliac crest.
All measurements were done in triplicate and the
mean was recorded.
Sleep studies: Of the 180 subjects, 104 underwent
polysomnograhy as described previously18. All
subjects underwent sleep study within one month of
completing the questionnaire. Subjects were asked not
to sleep in the afternoon on the day of study and not
to take alcohol anxiolytic/sedative drugs. The subject
was hooked to Alice 3 infant and adult computerized
polysomnography machine (Healthdyne
Technologies, USA) by standard gold cups after
cleansing the area of attachment by spirit followed by
Omni prep®. The subject was requested to sleep at
around 21:00 h. The recording of sleep study started
after ensuring that the impedance of recording
electrodes was set to zero. Various parameters
monitored included electroencephalogram (EEG),
electro-oculogram (EOG), electrocardiogram (ECG),
chin and leg electromyogram (EMG), nasal airflow,
tracheal breath sounds, thoracic wall and abdominal
movements, transcutaneous oxygen saturation, body
position and continuous positive airway pressure
(CPAP) titration, where required. All subjects
underwent polysomnograhy for at least 6 h. The sleep
data recorded by the computer were manually scored
for sleep stages, apnoeas, and hypopnoeas. The
apnoea was defined as cessation of oro-nasal airflow
for >10 sec. Obstructive apnoeas were scored when
airflow was absent but respiratory efforts were present.
Hypopnoea was defined as a discernible reduction in
respiratory airflow during a preceding period of
normal breathing for >10 sec accompanied by a
decrease of 4 per cent or more in oxyhaemoglobin
saturation during sleep. Apnoea-hypopnoea index
(AHI) was calculated based on the following formula:
AHI = (total no. of obstructive apnoeas + total no. of
hypopnoeas)/total sleep time in hours.
Statistical analysis: Data were recorded on a pre-
designed data sheet and managed on an ‘Excel’
spreadsheet. All entries were double checked for
any possible feeding error. Cronbach α value15 was
used for assessment of internal reliability between
responses to various questions or items in each
category. Coefficients above 0.7 are generally
regarded as acceptable, 0.8 and above are good and
0.9 and above are considered excellent.
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Anthropometric measurements and PSG findings in
cases and controls were compared using Student’s
t-test.  Chi-square test was used to study the
association between the outcome variable (AHI) and
various ordinal variables. Variables showing
statistically significant association at P<0.05 in
univariate analysis were considered as candidate
predictors to be used in multivariate analysis. Step-
wise multiple logistic regression analysis was used
to identify significant independent predictors for
OSA. Statistical analysis was performed using
statistical software package ‘STATA version 10.0’
[(intercooled version), Stata Corporation, Houston,
Texas, USA].
Results
Anthropometry and demography profile of cases
and controls: Subjects with polysomnographic
evidence of AHI >5/h were categorized as cases
(n=62) and the subjects with AHI <5/h as controls
(n=42) (Fig. 1).
SHARMA et al: MODIFIED BERLIN QUESTIONNAIRE FOR THE OSA SYNDROME 285
Table I. Demography and anthropometric characteristics in
cases and controls
Variable Cases Controls
(n=62) (n=42)
Age (yr) 43 ± 9** 36 ± 9
Neck circumference (cm) 40.3 ± 3.1** 35.6 ± 3.4
Neck length (cm) 10.7 ± 2.3 10.5 ± 2.4
PPNC (%) 100 ± 7.6** 89.2 ± 7.6
Body mass index (kg/m2) 30.9 ± 7.3** 24.2 ± 5.2
Waist hip ratio 1 ± 0.7** 0.9 ± 0.2
Mid arm circumference (cm) 33.5 ± 3.7** 28.9 ± 4.1
SSFT* (cm) 25.3 ± 9.9* 19.2 ± 9.2
SSFT* recorded in 45 cases and 42 controls. All data are
presented as mean (SD). PPNC = [(1000×NC)/(0.55 × H+310)].
PPNC, percentages of predicted neck circumference for height;
SSFT, sub-scapular skin fold thickness
P*<0.05, **<0.001 compared to controls
Values are shown as mean ± SD
Fig. 1. Administration of screening and modified Berlin questionnaires, risk grouping and results of study.
320 consecutive subjects were administered screening questionnaires
180 had positive response to at least to one question and modified Berlin
questionnaire was administered to all of them.
(140 subjects had negative response to the four screening questions)
High-risk group (80) Low risk group (100)
Drop outs n=25 (32%) Drop outs n=51 (51%)
Sleep studies done in 55 subjects sleep studies done in 49 subjects
53 2 9 40
PSG (+) PSG (-) PSG (+) PSG (-)
3
3
3
3 3
3 3 3 3
PSG, Polysomnography
Majority of the subjects were males (80%).
Cases had significantly higher neck circumference
and were older  than controls .  Stat is t ical ly
significant difference was observed between
percentages of predicted neck circumference for
height (PPNC) of cases and controls (P<0.001).
Neck length was not  s ignif icant ly different
between cases and control groups. BMI ranged
from 14.9 - 58.3. Seventy three per cent subjects
had BMI >25 but only 50 per cent patients felt they
were actually obese.  The difference in BMI
between cases and controls was statistically
significant (P<0.001) (Table I). Fifty six per cent
of the subjects were hypertensive. Only 40 per cent
of these subjects had their hypertension diagnosed
before they were included in the study. Remaining
16 per cent were detected as hypertensive during
this study.
The difference in WHR, mid-arm circumference
and SSFT between cases and controls was
statistically significant (P<0.001, 0.05).
Pulmonary function testing and upper airway (nasal
and pharyngeal) examination: Pulmonary function
testing results were available in 70 subjects. No
significant difference in FEV1, FEV1 / FVC, PEFR
and FVC was found between cases and controls.
Nasal and throat abnormalities were detected in 18
subjects and 86 subjects did not have any
abnormality. Seventeen (94%) subjects were cases
among the group of 18 subjects who had upper airway
abnormalities. The abnormalities included enlarged
tonsils, abnormal pharyngeal anatomy, nasal
obstruction due to deviated nasal septum and nasal
polyps.
Polysomnograhy results: Total duration of sleep
differed in both cases and control groups and was
statistically significant (P<0.05). Rapid eye
movement (REM) sleep between the groups was not
significantly different. Lowest baseline SpO2 was
84 per cent and it
 
was significantly lower (P<0.05)
in cases than in controls (Table II).
Validation of modified Berlin questionnaire: The
total number of patients in the present study was the
same as in the original study on the Berlin
questionnaire8. The high risk group subjects were low
in number. Specificity, positive predictive value and
negative predictive value were significantly higher
than in the earlier study on the Berlin questionnaire8.
Combined misclassification rate in the present study
was lower in the control group (5 vs 24%) as
compared to the earlier study on the Berlin
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Table II. Sleep study characteristics in cases and controls
Variable Cases Controls
(n=62) (n=42)
Total sleep time (min) 425.5 ± 77* 382.5 ± 6.4
Rapid eye movement 47.6 ± 40.9 41.3 ± 3.4
sleep (%)
Obstructive apnoeas (n) 104.9 ± 106** 1.6 ± 0.8
Baseline SpO2 (%) 94.4 ± 2.8* 95.9 ± 1.9
Minimum saturation 62 ± 21* 75 ± 20
during sleep (%)
All data are shown as mean ± SD
SpO2, arterial oxygen saturation as measured by pulse oximetry
during sleep
P*<0.05, **<0.001 compared to controls
Table III. Comparison of high risk and low risk groups using
apnoea/hypopnoea index (AHI) >5 as cut-off
PSG High risk Low risk Total
Cases (AHI >5) 53 (61*) 9 (6*) 62 (69*)
Controls (AHI <5) 2 (8*) 40 (25*) 42 (33*)
Total 55 (69*) 49 (31*) 104 (104*)
All data are shown in numbers. Definitions of high risk, low-
risks are provided in Material and Methods. *Numbers in
parentheses are results of Berlin study8
Sensitivity 86% (88*)
Specificity 95% (76*)
Positive predictive value 96% (88*)
Negative predictive value 82% (81*)
Misclassification rate in cases 14.5% (9*)
Misclassification rate in controls 5% (24*)
*Numbers in parentheses refer to numbers in the Berlin study
questionnaire. Misclassification rate was 19.3 per
cent in both cases and controls (Table III).
Distribution of AHI in the high and low risk groups:
A total of 48 subjects in the high risk group and 8 in the
low risk group had AHI >10, 43 subjects in the high
risk group and 7 in low risk group had AHI >15, whereas
35 subjects in the high risk group and 3 subjects in low
risk group had AHI >30 (Fig. 2).
Discussion
A number of epidemiological studies have been
performed all over the world in various ethnic and
racial groups to determine the prevalence of OSA
and OSAHS. Unfortunately data related to sleep
breathing disorders among Indians are sparse. It is a
prerequisite to have a symptoms questionnaire to
screen the patients at risk for OSAHS before a
polysomnography is done, due to its high cost and
non-availability at all centers in developing countries
like India where resources are limited. Having a
symptom-based questionnaire with good predictive
ability will avoid unnecessary sleep studies in the
subjects who are not at high risk for having OSA.
Therefore, a modified symptom-based questionnaire
was used to identify the patients at risk for OSA in
the Indian population. The modification was done to
suit questions to our population. The drop out rates
of 32 and 51 per cent in high and low risk groups
respectively were high since the subjects were
attending the hospital for non-sleep related problems.
Discrepancy in drop out rates was expected since high
risk group subjects with significant complaints, might
have become aware about the possible presence of
sleep apnoea in them. In the present study no data
were missing as it had happened in a few
questionnaire based studies13 in the past. This could
be attributed to the simple questions in the
questionnaire and filling by the subjects in the
presence of a qualified medical practitioner. Internal
reliability between responses to each category of
questions calculated by using Cronbach a
correlations15 showed values in good reliability range.
Based on responses to questionnaire, we calculated
snoring, choking, alcohol, smoking indices of which
choking and snoring indices were found to be
independent predictors of mild to moderate OSA
(AHI > 5-15/h) and moderate to severe OSA
(AHI > 30/h) respectively.
We used gold standard diagnostic study19
(overnight polysomnography) for our study
population. According to American20 and
Australasian guidelines21 also overnight
polysomnography is considered to be the gold
standard for diagnosis of OSA. International task
force22 on standardization of definition of sleep-
disordered breathing recommends AHI >15 per h as
cut-off. The definition of OSA is arbitrary, and it
has been suggested that an AHI >5/h is a low cut-off
value, especially for older people23,24 and many
studies have used higher cut -off values of AHI. AHI
>5 per h was used as cut-off for defining OSA, since
our study was performed to validate the questionnaire
in subjects at risk for OSA and not to identify the
patients with moderate and severe OSA.
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Fig. 2. The distribution of AHI in the high risk and low risk
groups.
Apnoea-hypopnoea Index (AHI)
High risk category
Low risk category
3-4 times a wk
1-2 times a wk
1-2 times a month
Never or nearly never
Category 2:
1. How often do your feel tired or fatigued after your sleep?
Nearly every day
3-4 times a wk
1-2 times a wk
1-2 times a month
Never or nearly never
2. During your wake time do you feel tired, fatigued or not up
to at par? If yes, how frequently?
Nearly every day
3-4 times a wk
1-2 times a wk
1-2 times a month
Never or nearly never
3. Have you ever fallen asleep while waiting in a line to meet
your doctor? If yes, how frequently?
Nearly in all visits
In 1-2 visits
In 3-4 visits
Never or nearly never
4. Have you ever fallen asleep while watching television at your
home during daytime? If yes, how frequently?
Nearly every day
3-4 times a wk
1-2 times a wk
1-2 times a month
Never or nearly never
5. Have you ever fallen asleep while waiting in a line to pay
your electricity and telephone bills? If yes, how frequently?
Nearly every visit
In 3-4 visits
In 1-2 visits
Never or nearly never
Category 3:
Do you have high blood pressure?
Yes
No
Don’t know
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Annexure-I
Screening questions:
1. Do you snore?
2. Do you feel tired after waking up from sleep?
3. Do you feel you are obese?
4. Are you a hypertensive?
Annexure-II
Modified Berlin questionnaire (used at AIIMS, New Delhi)
Category 1:
1. Do you snore?
Yes
No
Don’t know
2. Your snoring is
Slightly louder than breathing
As loud as talking
Louder than talking
Very loud can be heard in adjacent rooms
3. How often do you snore?
Nearly every day
3-4 times a wk
1-2 times a wk
1-2 times a month
Never or nearly never
4. Has your snoring ever bothered other people?
Yes
No
5. Has anyone noticed that you quit breathing during your sleep?
If yes, how frequently?
Nearly every day
3-4 times a wk
1-2 times a wk
1-2 times a month
Never or nearly never
6. Do you choke while you are sleeping? If yes, how frequently?
Nearly every day
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Prevalence. Am J Respir Crit Care Med 1995; 152 : 711-5.
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clinically diagnosed proportion of sleep apnea syndrome in
middle aged men and women. Sleep 1997; 20 : 705-6.
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risk factors of obstructive sleep apnea syndrome in a
population of Delhi, India. Chest 2006; 130 : 149-56.
6. Ball EM, Simon RD Jr., Tall AA, Banks MB, Nino-Murcia
G. Dement WC. Diagnosis and treatment of sleep apnea
within the community. The Walla Walla Project. Arch Intern
Med 1997; 157 : 419-24.
7. Haponik EF, Frye AW, Richards B, Wymer A, Hinds A,
Pearce K, et al. Sleep history is neglected diagnostic
information. Challenges for primary care physicians. J Gen
Intern Med 1996; 11 : 759-6.
8. Netzer NC, Stoohs SA, Netzer CM, Clark K, Strohl KP.
Using the Berlin questionnaire to identify patients at risk
for the sleep apnea syndrome. Ann Intern Med 1999; 131 :
485-91.
9. Ciurigniotta F, D’ Alessandro R, Partinen M, Zucconi M,
Cristina E, Gerardi R, et al. Prevalence of every night snoring
and obstructive sleep apneas among 30-69 year old men in
Bologna, Italy. Acta Neurol Scand 1989; 79 : 366-72.
10. Kapunlal LE, Andrew DJ, Crowell DH, Pearce JW.
Identifying sleep apnea from self reports. Sleep 1998; 11 :
430-6.
11. Flemons WW, Whitelaw WA, Brant R, Remmers JE.
Likelihood ratios for a sleep apnea clinical prediction rule.
Am J Respir Crit Care Med 1994; 150 : 1279-85.
12. Hemons WW, Remmers JE. The diagnosis of sleep apnea
questionnaires and home studies. Sleep 1996; 19 (10 Suppl)
: 8243-7.
13. Kump K, Whalen C, Tishler PV, Browner I, Ferrette V,
Strohl KP, et al. Assessment of the validity and utility of a
sleep symptom questionnaire. Am J Respir Crit Care Med
1994; 150 : 735-41.
14. Wu H, Yan-Go F. Self reported automobile accidents
involving patients with obstructive sleep apnea. Neurology
1996; 46 : 1254-7.
The BMI >25 kg/m2 was used as cut-off for
obesity17. The mean BMI was significantly higher
in cases than the controls.  Both BMI and
hypertension appeared to be associated with habitual
snoring and OSA. A similar association was found
in the Berlin questionnaire8. The predictive value
of this combination of symptoms was high. Various
studies have reported frequency of hypertension 40-
80 per cent25 in OSA. In the present study the
frequency of hypertension among cases was 53 per
cent. The JNC VI classification16 was used as JNC
VII classification was not available when this study
was started. These results are in accordance with
results of other studies25.
To conclude, the modified Berlin questionnaire
evaluated in Indians was found to be valid and
applicable due to the following reasons: (i) The
internal reliability was good among the responses to
questions asked in each category. ( ii) Risk
categorization done on the basis of the modified
Berlin questionnaire emerged as a good independent
predictor for the presence of both mild and moderate
OSA. Further validation of the modified Berlin
questionnaire need to be done in large samples in
different parts of the country.
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